We are live on ! Find out more
UNH icon

UnitedHealth

1,965 hedge funds and large institutions have $201B invested in UnitedHealth in 2019 Q2 according to their latest regulatory filings, with 147 funds opening new positions, 897 increasing their positions, 720 reducing their positions, and 104 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more first-time investments, than exits

New positions opened: 147 | Existing positions closed: 104

25% more repeat investments, than reductions

Existing positions increased: 897 | Existing positions reduced: 720

1% more funds holding

Funds holding: 1,9441,965 (+21)

1% more call options, than puts

Call options by funds: $1.68B | Put options by funds: $1.66B

0.69% more ownership

Funds ownership: 86%86.69% (+0.69%)

1% less capital invested

Capital invested by funds: $204B → $201B (-$2.56B)

15% less funds holding in top 10

Funds holding in top 10: 176149 (-27)

Holders
1,965
Holders Change
+21
Holders Change %
+1.08%
% of All Funds
42.67%
Holding in Top 10
149
Holding in Top 10 Change
-27
Holding in Top 10 Change %
-15.34%
% of All Funds
3.24%
New
147
Increased
897
Reduced
720
Closed
104
Calls
$1.68B
Puts
$1.66B
Net Calls
+$15.9M
Net Calls Change
-$66M
Name Holding Trade Value Shares
Change
Change in
Stake
PMAM
376
Picton Mahoney Asset Management
Ontario, Canada
$21.1M -$4.98M -20,700 -19%
CNAM
377
Campbell Newman Asset Management
Wisconsin
$21M +$230K +958 +1%
Creative Planning
378
Creative Planning
Kansas
$21M +$1.08M +4,480 +5%
AC
379
Allstate Corporation
Illinois
$20.9M +$2.62M +10,896 +15%
MCM
380
MAI Capital Management
Ohio
$20.9M +$354K +1,472 +2%
MNBTD
381
Moody National Bank Trust Division
Texas
$20.6M -$4.01M -16,659 -17%
CSS
382
Cubist Systematic Strategies
Connecticut
$20.5M +$18.3M +75,906 +917%
FDCDDQ
383
Federation des caisses Desjardins du Quebec
Quebec, Canada
$20.5M +$7.29M +30,308 +57%
CFB
384
Cullen/Frost Bankers
Texas
$20.3M -$3.14M -13,062 -14%
CTC
385
Central Trust Company
Missouri
$20.3M -$508K -2,113 -3%
KeyBank National Association
386
KeyBank National Association
Ohio
$20.2M +$548K +2,279 +3%
CCM
387
Chilton Capital Management
Texas
$20.1M +$4.67M +19,419 +31%
BPCE
388
Bank Pictet & Cie (Europe)
Germany
$20M +$836K +3,475 +4%
OAM
389
Oppenheimer Asset Management
New York
$20M -$92.6K -385 -0.5%
AIM
390
Achmea Investment Management
Netherlands
$20M -$4.49M -18,680 -19%
AC
391
Alleghany Corporation
New York
$19.8M +$19.5M +81,000 New
RBCM
392
Raub Brock Capital Management
California
$19.7M -$25K -104 -0.1%
MIH
393
Meitav Investment House
Israel
$19.7M +$18.6M +77,315 +2,209%
FCI
394
Financial Counselors Inc
Kansas
$19.7M +$776K +3,227 +4%
CBOA
395
Commonwealth Bank of Australia
Australia
$19.7M -$5.38M -22,356 -22%
MML Investors Services
396
MML Investors Services
Massachusetts
$19.7M +$2.04M +8,466 +12%
TMAM
397
Tokio Marine Asset Management
Japan
$19.5M +$917K +3,814 +5%
Federated Hermes
398
Federated Hermes
Pennsylvania
$19.4M -$1.93M -8,010 -9%
RIG
399
Roosevelt Investment Group
New York
$19.4M -$112K -464 -0.6%
ABC
400
Associated Banc-Corp
Wisconsin
$19.4M -$93.1K -387 -0.5%

UNH Hedge Fund Activity: Q2 2019 in Review

1,965 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in UnitedHealth (UNH) for Q2 2019, worth a combined $201B — down 1.3% from $204B a quarter earlier.

Buyers outnumbered sellers: 147 funds opened new UNH positions and 104 closed out — a net gain of 43 holders — while 897 added to existing stakes and 720 trimmed.

The largest buyer was Nuveen, adding an estimated $1.91B. The largest seller was T. Rowe Price Associates, cutting an estimated $2.27B.

  • 1,965 institutional investors held UnitedHealth (UNH) as of Q2 2019, up from 1,944 in Q1 2019.
  • Funds reported $201B of UnitedHealth stock for Q2 2019, down 1.3% quarter-over-quarter.
  • 147 funds opened new UnitedHealth positions in Q2 2019 and 104 closed out, a net change of +43 holders.
  • The largest UnitedHealth buyer in Q2 2019 was Nuveen, an estimated $1.91B added.
  • The largest UnitedHealth seller in Q2 2019 was T. Rowe Price Associates, an estimated $2.27B sold.

Based on aggregated 13F filings for Q2 2019.